title: The effect of nicotine induced behavioral sensitization on dopamine D1 receptor pharmacology: An in vivo and ex vivo study in the rat.
abstract: Behavioral sensitization is a phenomenon which can develop following repeated intermittent administration of a range of psychostimulants, and other compounds, and may model neuroplastic changes seen in addictive processes and neuropsychiatric disease. The aim of the present study was to investigate the effect of dopamine D1 receptor (D1R) ligands on nicotine-induced behavioral sensitization and their molecular consequences in the striatum. Wistar rats were chronically treated (5 days) with vehicle or nicotine (0.4 mg/kg; s.c.) and locomotor activity was measured. Following a 5 day withdrawal period, rats were pretreated with vehicle or the D1R antagonist SCH-23390 (0.03 mg/kg; i.p.) and challenged with nicotine. Either 45 min or 24h post-challenge, the striatum was isolated and ex vivo receptor binding and cAMP accumulation (using LC-MS/MS) were assessed. It was shown that chronic nicotine administration induced the development and expression of locomotor sensitization, of which the latter was blocked by SCH-23390. Nicotine-induced sensitization had no effect on forskolin stimulated cAMP accumulation but increased the efficacy of dopamine for the D1R and decreased the potency of D1R agonists. These effects were antagonized by in vivo pre-challenge with SCH-23390. No effect on D1 receptor binding was observed. Moreover, time dependent effects were observed between tissue taken 45 min and 24h post-challenge. The present findings provide a connection between behavioral sensitization and intracellular cAMP accumulation through the D1R. Together these data suggest that changes in D1R signaling in the dorsal striatum may play an important role in the underlying mechanisms of nicotine-induced behavioral sensitization.
authors: Abbott Healthcare Products B.V. (formerly Solvay Pharmaceuticals B.V.), C.J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands; Department of Chemistry, National University of Ireland Maynooth, Maynooth, Co. Kildare, Ireland.
authors: W
authors: W
authors: Goutier
authors: UCD School of Biomolecular and Biomedical Science, Conway Institute of Biomolecular and Biomedical Research, Belfield, Dublin 4, Ireland; Department of Chemistry, National University of Ireland Maynooth, Maynooth, Co. Kildare, Ireland.
authors: J J
authors: JJ
authors: O'Connor
authors: Department of Chemistry, National University of Ireland Maynooth, Maynooth, Co. Kildare, Ireland.
authors: J P
authors: JP
authors: Lowry
authors: Abbott Healthcare Products B.V. (formerly Solvay Pharmaceuticals B.V.), C.J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands. Electronic address: andymccreary@yahoo.co.uk.
authors: A C
authors: AC
authors: McCreary
mesh_terms: D000255:Adenosine Triphosphate / Q000378:metabolism; D000704:Analysis of Variance; D000818:Animals; D001552:Benzazepines / Q000494:pharmacology; D005576:Colforsin; D000242:Cyclic AMP / Q000378:metabolism; D015259:Dopamine Agents / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D055664:Electrochemical Techniques; D008297:Male; D009043:Motor Activity / Q000187:drug effects*; D009538:Nicotine / Q000494:pharmacology*; D018722:Nicotinic Agonists / Q000494:pharmacology*; D011485:Protein Binding / Q000187:drug effects; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar; D017447:Receptors, Dopamine D1 / Q000378:metabolism*; D013997:Time Factors; D014316:Tritium / Q000493:pharmacokinetics
chemical_list: D001552:Benzazepines; D015259:Dopamine Agents; D018722:Nicotinic Agonists; D017447:Receptors, Dopamine D1; C534628:SCH 23390; D014316:Tritium; D005576:Colforsin; D009538:Nicotine; D000255:Adenosine Triphosphate; D000242:Cyclic AMP
keywords: Behavioral sensitization; Dopamine D(1); Nicotine; Receptor binding; SCH-23390; cAMP